These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19463894)

  • 1. Increased MMP-3 and CTGF expression during lipopolysaccharide-induced dopaminergic neurodegeneration.
    McClain JA; Phillips LL; Fillmore HL
    Neurosci Lett; 2009 Aug; 460(1):27-31. PubMed ID: 19463894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally.
    Ling Z; Zhu Y; Tong Cw; Snyder JA; Lipton JW; Carvey PM
    Exp Neurol; 2006 Jun; 199(2):499-512. PubMed ID: 16504177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Protective effects of doxycycline upon dopaminergic neuron in LPS-induced rat model of Parkinson's disease].
    Wang PQ; Sun SG; Qiao X
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(19):1346-50. PubMed ID: 19615192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide.
    Wang S; Yan JY; Lo YK; Carvey PM; Ling Z
    Brain Res; 2009 Apr; 1265():196-204. PubMed ID: 19236855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective changes in gene expression in cortical regions sensitive to amphetamine during the neurodegenerative process.
    Bowyer JF; Harris AJ; Delongchamp RR; Jakab RL; Miller DB; Little AR; O'Callaghan JP
    Neurotoxicology; 2004 Jun; 25(4):555-72. PubMed ID: 15183010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease.
    Engler H; Doenlen R; Riether C; Engler A; Niemi MB; Besedovsky HO; del Rey A; Pacheco-López G; Feldon J; Schedlowski M
    Brain Behav Immun; 2009 May; 23(4):518-26. PubMed ID: 19486644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease.
    Kim S; Moon M; Park S
    J Endocrinol; 2009 Sep; 202(3):431-9. PubMed ID: 19570816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on changes of MMP-3 expression after brain contusion in rats.
    Li RB; Guo XC; Liang HX; Wang FY; Zhu BL
    Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S176-9. PubMed ID: 19329348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity.
    Li Z; Choi DY; Shin EJ; Hunter RL; Jin CH; Wie MB; Kim MS; Park SJ; Bing G; Kim HC
    Neurosci Lett; 2008 Nov; 445(1):1-6. PubMed ID: 18760329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Habituation of the head-shake response induces changes in brain matrix metalloproteinases-3 (MMP-3) and -9.
    Wright JW; Meighan SE; Murphy ES; Holtfreter KL; Davis CJ; Olson ML; Benoist CC; Muhunthan K; Harding JW
    Behav Brain Res; 2006 Nov; 174(1):78-85. PubMed ID: 16916548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells.
    Gressner OA; Lahme B; Siluschek M; Gressner AM
    Liver Int; 2009 Jul; 29(6):886-97. PubMed ID: 19291178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide-induced functional and structural injury of the mitochondria in the nigrostriatal pathway.
    Hunter R; Ojha U; Bhurtel S; Bing G; Choi DY
    Neurosci Res; 2017 Jan; 114():62-69. PubMed ID: 27667002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation.
    Chen HQ; Jin ZY; Wang XJ; Xu XM; Deng L; Zhao JW
    Neurosci Lett; 2008 Dec; 448(2):175-9. PubMed ID: 18952146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation.
    Mun-Bryce S; Lukes A; Wallace J; Lukes-Marx M; Rosenberg GA
    Brain Res; 2002 Apr; 933(1):42-9. PubMed ID: 11929634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of LPS-induced neuroinflammation on acetylcholinesterase activity in rat brain.
    Tyagi E; Agrawal R; Nath C; Shukla R
    J Neuroimmunol; 2008 Dec; 205(1-2):51-6. PubMed ID: 18838174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippocampal MMP-3 elevation is associated with passive avoidance conditioning.
    Olson ML; Meighan PC; Brown TE; Asay AL; Benoist CC; Harding JW; Wright JW
    Regul Pept; 2008 Feb; 146(1-3):19-25. PubMed ID: 17698214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal lipopolysaccharide does not accelerate progressive dopamine neuron loss in the rat as a result of normal aging.
    Ling Z; Zhu Y; Tong CW; Snyder JA; Lipton JW; Carvey PM
    Exp Neurol; 2009 Apr; 216(2):312-20. PubMed ID: 19133261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease.
    Marinova-Mutafchieva L; Sadeghian M; Broom L; Davis JB; Medhurst AD; Dexter DT
    J Neurochem; 2009 Aug; 110(3):966-75. PubMed ID: 19549006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease.
    Cheng B; Yang X; An L; Gao B; Liu X; Liu S
    Brain Res; 2009 Aug; 1286():25-31. PubMed ID: 19559687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases.
    Langenfurth A; Rinnenthal JL; Vinnakota K; Prinz V; Carlo AS; Stadelmann C; Siffrin V; Peaschke S; Endres M; Heppner F; Glass R; Wolf SA; Kettenmann H
    J Neurosci Res; 2014 Mar; 92(3):275-86. PubMed ID: 24323769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.